Alternative Diagnostic Biomarkers in Adrenal Disorders

Overview

About this study

The purpose of this study is to determine the diagnostic accuracy of salivary cortisol and cortisone in diagnosing Mild autonomous cortisol secretion.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults evaluated for adrenal disorders or adults without a known adrenal disorder.
  • Able to sign consent.

Exclusion criteria

  • Unwilling to follow at least one study procedure.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/1/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Irina Bancos, M.D., M.S.

Open for enrollment

Contact information:

Vanessa Fell M.A.

(507) 266-6068

Fell.Vanessa@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20568896

Mayo Clinic Footer